Oertel M - Search Results

1

Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death.

Mooli RGR, Mukhi D, Watt M, Nagati V, Reed SM, Gandhi NK, Oertel M, Ramakrishnan SK. Mooli RGR, et al. Among authors: oertel m. Int J Mol Sci. 2024 Dec 6;25(23):13114. doi: 10.3390/ijms252313114. Int J Mol Sci. 2024. PMID: 39684823 Free PMC article.

2

Mechanism and Effect of HNF4α Decrease in a Rat Model of Cirrhosis and Liver Failure.

Melis M, Marino R, Tian J, Johnson C, Sethi R, Oertel M, Fox IJ, Locker J. Melis M, et al. Among authors: oertel m. Cell Mol Gastroenterol Hepatol. 2024;17(3):453-479. doi: 10.1016/j.jcmgh.2023.11.009. Epub 2023 Nov 21. Cell Mol Gastroenterol Hepatol. 2024. PMID: 37993018 Free PMC article.

3

Antagonizing Activin A/p15^INK4b Signaling as Therapeutic Strategy for Liver Disease.

Mekala S, Rai R, Reed SL, Bowen B, Michalopoulos GK, Locker J, Raeman R, Oertel M. Mekala S, et al. Among authors: oertel m. Cells. 2024 Apr 8;13(7):649. doi: 10.3390/cells13070649. Cells. 2024. PMID: 38607090 Free PMC article.

4

Therapeutic Cell Repopulation of the Liver: From Fetal Rat Cells to Synthetic Human Tissues.

Shafritz DA, Ebrahimkhani MR, Oertel M. Shafritz DA, et al. Among authors: oertel m. Cells. 2023 Feb 6;12(4):529. doi: 10.3390/cells12040529. Cells. 2023. PMID: 36831196 Free PMC article. Review.

5

Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.

Park Y, Hu S, Kim M, Oertel M, Singhi A, Monga SP, Liu S, Ko S. Park Y, et al. Among authors: oertel m. Cells. 2024 Aug 29;13(17):1451. doi: 10.3390/cells13171451. Cells. 2024. PMID: 39273023 Free PMC article.

6

Inhibiting Wnt Signaling Reduces Cholestatic Injury by Disrupting the Inflammatory Axis.

Ayers M, Kosar K, Xue Y, Goel C, Carson M, Lee E, Liu S, Brooks E, Cornuet P, Oertel M, Bhushan B, Nejak-Bowen K. Ayers M, et al. Among authors: oertel m. Cell Mol Gastroenterol Hepatol. 2023;16(6):895-921. doi: 10.1016/j.jcmgh.2023.08.004. Epub 2023 Aug 12. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37579970 Free PMC article.

7

Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation.

Baehr A, Schäfer S, Jäckel M, Becker SA, Ghandili S, Grohmann M, Eich HT, Oertel M. Baehr A, et al. Among authors: oertel m. Cancers (Basel). 2024 Dec 22;16(24):4265. doi: 10.3390/cancers16244265. Cancers (Basel). 2024. PMID: 39766164 Free PMC article.

8

[Came to stay? Nivolumab in first-line treatment of advanced stage Hodgkin's lymphoma-A radiotherapeutic afterthought of the SWOG S1826 study].

Oertel M, Eich HT. Oertel M, et al. Strahlenther Onkol. 2025 Jan 3. doi: 10.1007/s00066-024-02353-0. Online ahead of print. Strahlenther Onkol. 2025. PMID: 39753914 German. No abstract available.

9

Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?

Levis M, Oertel M. Levis M, et al. Among authors: oertel m. Semin Radiat Oncol. 2025 Jan;35(1):16-26. doi: 10.1016/j.semradonc.2024.07.013. Semin Radiat Oncol. 2025. PMID: 39672638 Free article. Review.

10

[Improved prognosis with radiotherapy in early-stage Hodgkin lymphoma: a critical analysis of the long-term data from the EORTC/LYSA/FIL H10 trial].

Oertel M, Eich HT. Oertel M, et al. Strahlenther Onkol. 2024 Nov 30. doi: 10.1007/s00066-024-02325-4. Online ahead of print. Strahlenther Onkol. 2024. PMID: 39616285 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters